241 related articles for article (PubMed ID: 15478191)
21. Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts.
Turner BJ; Lopes EC; Cheema SS
J Cell Biochem; 2004 Apr; 91(5):1074-84. PubMed ID: 15034941
[TBL] [Abstract][Full Text] [Related]
22. Mutant SOD1 alters the motor neuronal transcriptome: implications for familial ALS.
Kirby J; Halligan E; Baptista MJ; Allen S; Heath PR; Holden H; Barber SC; Loynes CA; Wood-Allum CA; Lunec J; Shaw PJ
Brain; 2005 Jul; 128(Pt 7):1686-706. PubMed ID: 15872021
[TBL] [Abstract][Full Text] [Related]
23. Opposing effects of low and high-dose clozapine on survival of transgenic amyotrophic lateral sclerosis mice.
Turner BJ; Rembach A; Spark R; Lopes EC; Cheema SS
J Neurosci Res; 2003 Nov; 74(4):605-13. PubMed ID: 14598305
[TBL] [Abstract][Full Text] [Related]
24. Mutant SOD1-induced neuronal toxicity is mediated by increased mitochondrial superoxide levels.
Zimmerman MC; Oberley LW; Flanagan SW
J Neurochem; 2007 Aug; 102(3):609-18. PubMed ID: 17394531
[TBL] [Abstract][Full Text] [Related]
25. VEGF-induced activation of the PI3-K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death.
Li B; Xu W; Luo C; Gozal D; Liu R
Brain Res Mol Brain Res; 2003 Mar; 111(1-2):155-64. PubMed ID: 12654515
[TBL] [Abstract][Full Text] [Related]
26. Heterodimer formation of wild-type and amyotrophic lateral sclerosis-causing mutant Cu/Zn-superoxide dismutase induces toxicity independent of protein aggregation.
Witan H; Kern A; Koziollek-Drechsler I; Wade R; Behl C; Clement AM
Hum Mol Genet; 2008 May; 17(10):1373-85. PubMed ID: 18211954
[TBL] [Abstract][Full Text] [Related]
27. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
Watanabe S; Nagano S; Duce J; Kiaei M; Li QX; Tucker SM; Tiwari A; Brown RH; Beal MF; Hayward LJ; Culotta VC; Yoshihara S; Sakoda S; Bush AI
Free Radic Biol Med; 2007 May; 42(10):1534-42. PubMed ID: 17448900
[TBL] [Abstract][Full Text] [Related]
28. Brain beta-amyloid accumulation in transgenic mice expressing mutant superoxide dismutase 1.
Turner BJ; Li QX; Laughton KM; Masters CL; Lopes EC; Atkin JD; Cheema SS
Neurochem Res; 2004 Dec; 29(12):2281-6. PubMed ID: 15672551
[TBL] [Abstract][Full Text] [Related]
29. Superoxide dismutase 1 mutants related to amyotrophic lateral sclerosis induce endoplasmic stress in neuro2a cells.
Oh YK; Shin KS; Yuan J; Kang SJ
J Neurochem; 2008 Feb; 104(4):993-1005. PubMed ID: 18233996
[TBL] [Abstract][Full Text] [Related]
30. Absence of p53: no effect in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kuntz C; Kinoshita Y; Beal MF; Donehower LA; Morrison RS
Exp Neurol; 2000 Sep; 165(1):184-90. PubMed ID: 10964497
[TBL] [Abstract][Full Text] [Related]
31. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Reinholz MM; Merkle CM; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
[TBL] [Abstract][Full Text] [Related]
32. Role of heat shock response and Hsp27 in mutant SOD1-dependent cell death.
Krishnan J; Lemmens R; Robberecht W; Van Den Bosch L
Exp Neurol; 2006 Aug; 200(2):301-10. PubMed ID: 16806187
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotective Effects of Genistein in a SOD1-G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Zhao Z; Fu J; Li S; Li Z
J Neuroimmune Pharmacol; 2019 Dec; 14(4):688-696. PubMed ID: 31321663
[TBL] [Abstract][Full Text] [Related]
34. Notch pathway is activated in cell culture and mouse models of mutant SOD1-related familial amyotrophic lateral sclerosis, with suppression of its activation as an additional mechanism of neuroprotection for lithium and valproate.
Wang SY; Ren M; Jiang HZ; Wang J; Jiang HQ; Yin X; Qi Y; Wang XD; Dong GT; Wang TH; Yang YQ; Feng HL
Neuroscience; 2015 Aug; 301():276-88. PubMed ID: 26067594
[TBL] [Abstract][Full Text] [Related]
35. Small-molecule-mediated stabilization of familial amyotrophic lateral sclerosis-linked superoxide dismutase mutants against unfolding and aggregation.
Ray SS; Nowak RJ; Brown RH; Lansbury PT
Proc Natl Acad Sci U S A; 2005 Mar; 102(10):3639-44. PubMed ID: 15738401
[TBL] [Abstract][Full Text] [Related]
36. Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS.
Rembach A; Turner BJ; Bruce S; Cheah IK; Scott RL; Lopes EC; Zagami CJ; Beart PM; Cheung NS; Langford SJ; Cheema SS
J Neurosci Res; 2004 Aug; 77(4):573-82. PubMed ID: 15264227
[TBL] [Abstract][Full Text] [Related]
37. Amyotrophic lateral sclerosis: delayed disease progression in mice by treatment with a cannabinoid.
Raman C; McAllister SD; Rizvi G; Patel SG; Moore DH; Abood ME
Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Mar; 5(1):33-9. PubMed ID: 15204022
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of Homer1b/c in SOD1 G93A Models of ALS: A Novel Mechanism of Neuroprotective Effect of Lithium and Valproic Acid.
Jiang HZ; Wang SY; Yin X; Jiang HQ; Wang XD; Wang J; Wang TH; Qi Y; Yang YQ; Wang Y; Zhang CT; Feng HL
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999308
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic benefit of intrathecal injection of insulin-like growth factor-1 in a mouse model of Amyotrophic Lateral Sclerosis.
Nagano I; Ilieva H; Shiote M; Murakami T; Yokoyama M; Shoji M; Abe K
J Neurol Sci; 2005 Aug; 235(1-2):61-8. PubMed ID: 15990113
[TBL] [Abstract][Full Text] [Related]
40. Modeling amyotrophic lateral sclerosis in hSOD1 transgenic swine.
Chieppa MN; Perota A; Corona C; Grindatto A; Lagutina I; Vallino Costassa E; Lazzari G; Colleoni S; Duchi R; Lucchini F; Caramelli M; Bendotti C; Galli C; Casalone C
Neurodegener Dis; 2014; 13(4):246-54. PubMed ID: 24157939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
